XLNX Fundamental Analysis - XILINX INC

Name: XILINX INC (XLNX) Stock
Brand: XILINX INC
Rating: 6 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to XLNX. XLNX was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of XLNX have multiple concerns. XLNX is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

XLNX had positive earnings in the past year.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	14.64%
ROE	25.28%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

		Industry Rank	Sector Rank
OM	26.39%
PM (TTM)	25.26%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

XLNX has more shares outstanding than it did 1 year ago.

Compared to 1 year ago, XLNX has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 13.19 indicates that XLNX is not in any danger for bankruptcy at the moment.

XLNX has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.

		Industry Rank	Sector Rank
Debt/Equity	0.41
Debt/FCF	N/A
Altman-Z	13.19

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

XLNX has a Current Ratio of 6.62. This indicates that XLNX is financially healthy and has no problem in meeting its short term obligations.

XLNX has a Quick Ratio of 6.13. This indicates that XLNX is financially healthy and has no problem in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	6.62
Quick Ratio	6.13

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

XLNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.98%, which is quite impressive.

The Earnings Per Share has been growing slightly by 4.85% on average over the past years.

XLNX shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.43%.

The Revenue has been growing slightly by 7.29% on average over the past years.

EPS 1Y (TTM)45.98%

EPS 3Y-2.2%

EPS 5Y4.85%

EPS Q2Q%86.96%

Revenue 1Y (TTM)20.43%

Revenue growth 3Y8.46%

Revenue growth 5Y7.29%

Sales Q2Q%25.85%

3.2 Future

XLNX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.30% yearly.

XLNX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.09% yearly.

EPS Next Y57.65%

EPS Next 2Y30.1%

EPS Next 3Y25.35%

EPS Next 5Y19.3%

Revenue Next Year23.37%

Revenue Next 2Y16.28%

Revenue Next 3Y13.42%

Revenue Next 5Y11.09%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 51.16 indicates a quite expensive valuation of XLNX.

XLNX is valuated expensively when we compare the Price/Earnings ratio to 26.28, which is the current average of the S&P500 Index.

With a Price/Forward Earnings ratio of 44.12, XLNX can be considered very expensive at the moment.

Compared to an average S&P500 Price/Forward Earnings ratio of 33.61, XLNX is valued a bit more expensive.

		Industry Rank	Sector Rank
PE	51.16
Fwd PE	44.12

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	39.69

4.3 Compensation for Growth

XLNX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as XLNX's earnings are expected to grow with 25.35% in the coming years.

PEG (NY)0.89

PEG (5Y)10.56

EPS Next 2Y30.1%

EPS Next 3Y25.35%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

XLNX has a yearly dividend return of 0.76%, which is pretty low.

With a Dividend Yield of 0.76, XLNX pays less dividend than the S&P500 average, which is at 2.36.

		Industry Rank	Sector Rank
Dividend Yield	0.76%

5.2 History

The dividend of XLNX has a limited annual growth rate of 2.55%.

XLNX has been paying a dividend for at least 10 years, so it has a reliable track record.

Dividend Growth(5Y)2.55%

Div Incr YearsN/A

Div Non Decr YearsN/A

5.3 Sustainability

9.87% of the earnings are spent on dividend by XLNX. This is a low number and sustainable payout ratio.

The dividend of XLNX is growing, but earnings are growing more, so the dividend growth is sustainable.

DP9.87%

EPS Next 2Y30.1%

EPS Next 3Y25.35%

More info and screens

Find the best dividend stocks

Show peers with best dividend

XILINX INC

NASDAQ:XLNX (2/11/2022, 8:00:02 PM)

After market: 193.05 -1.87 (-0.96%)

194.92

-21.63 (-9.99%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSemiconductors & Semiconductor Equipment

GICS IndustrySemiconductors & Semiconductor Equipment

Earnings (Last)N/A N/A

Earnings (Next)02-08 2022-02-08/amc

Inst Owners0%

Inst Owner Change0%

Ins Owners0.17%

Ins Owner Change0%

Market Cap48.41B

Revenue(TTM)3.68B

Net Income(TTM)928.85M

Analysts67.2

Price Target192.41 (-1.29%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.76%

Yearly Dividend1.51

Dividend Growth(5Y)2.55%

DP9.87%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	51.16
Fwd PE	44.12
P/S	13.17
P/FCF	N/A
P/OCF	N/A
P/B	13.18
P/tB	N/A
EV/EBITDA	39.69

EPS(TTM)3.81

EY1.95%

EPS(NY)4.42

Fwd EY2.27%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS14.8

BVpS14.79

TBVpSN/A

PEG (NY)0.89

PEG (5Y)10.56

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	14.64%
ROE	25.28%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	26.39%
PM (TTM)	25.26%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3Y0%

ROICexgc growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score7

Asset Turnover0.58

Health

		Industry Rank	Sector Rank
Debt/Equity	0.41
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	6.62
Quick Ratio	6.13
Altman-Z	13.19

F-Score7

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)45.98%

EPS 3Y-2.2%

EPS 5Y4.85%

EPS Q2Q%86.96%

EPS Next Y57.65%

EPS Next 2Y30.1%

EPS Next 3Y25.35%

EPS Next 5Y19.3%

Revenue 1Y (TTM)20.43%

Revenue growth 3Y8.46%

Revenue growth 5Y7.29%

Sales Q2Q%25.85%

Revenue Next Year23.37%

Revenue Next 2Y16.28%

Revenue Next 3Y13.42%

Revenue Next 5Y11.09%

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

XILINX INC / XLNX FAQ

What is the fundamental rating for XLNX stock?

ChartMill assigns a fundamental rating of 7 / 10 to XLNX.

What is the valuation status for XLNX stock?

ChartMill assigns a valuation rating of 2 / 10 to XILINX INC (XLNX). This can be considered as Overvalued.

Can you provide the profitability details for XILINX INC?

XILINX INC (XLNX) has a profitability rating of 7 / 10.

What is the valuation of XILINX INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for XILINX INC (XLNX) is 51.16 and the Price/Book (PB) ratio is 13.18.

How sustainable is the dividend of XILINX INC (XLNX) stock?

The dividend rating of XILINX INC (XLNX) is 5 / 10 and the dividend payout ratio is 9.87%.

XILINX INC (XLNX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

XILINX INC / XLNX FAQ

What is the fundamental rating for XLNX stock?

What is the valuation status for XLNX stock?

Can you provide the profitability details for XILINX INC?

What is the valuation of XILINX INC based on its PE and PB ratios?

How sustainable is the dividend of XILINX INC (XLNX) stock?